AKLI - Akili Inc Stock Price, Fair Value and News

0.43USD0.00 (0.00%)Delayed

Market Summary

USD0.430.00

Delayed

0.00%

AKLI Stock Price

View Fullscreen

AKLI RSI Chart

AKLI Valuation

Market Cap

33.8M

Price/Earnings (Trailing)

-0.7

Price/Sales (Trailing)

20.16

EV/EBITDA

0.64

Price/Free Cashflow

-0.69

AKLI Price/Sales (Trailing)

AKLI Profitability

Operating Margin

49.05%

EBT Margin

-2889.87%

Return on Equity

-96.69%

Return on Assets

-72.06%

Free Cashflow Yield

-144.18%

AKLI Fundamentals

AKLI Revenue

Rev. Growth (Yr)

266.86%

Rev. Growth (Qtr)

54.12%

AKLI Earnings

Earnings (TTM)

-48.5M

Earnings Growth (Yr)

52.86%

Earnings Growth (Qtr)

12.42%

Breaking Down AKLI Revenue

Last 30 days

104.8%

Last 90 days

79.2%

How does AKLI drawdown profile look like?

AKLI Financial Health

Current Ratio

5.8

AKLI Investor Care

Shares Dilution (1Y)

0.73%

Diluted EPS (TTM)

-0.61

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	0	0	0	0
2023	774.7K	1.2M	0	1.7M
2022	484.3K	430.5K	376.8K	323.0K
2021	0	2.8M	1.7M	538.0K
2020	0	0	0	3.9M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Akili Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
May 02, 2024	martucci walter edward ii	sold (taxes)	-2,115	0.4088	-5,174	-
May 02, 2024	studer jacqueline	sold (taxes)	-752	0.4088	-1,840	chief legal officer
Mar 10, 2024	franklin matthew	sold (taxes)	-549	0.34	-1,615	president & ceo
Mar 10, 2024	martucci walter edward ii	sold (taxes)	-883	0.34	-2,599	-
Mar 10, 2024	studer jacqueline	sold (taxes)	-350	0.34	-1,032	chief legal officer
Dec 07, 2023	shanbhag santosh	acquired	-	-	69,750	chief financial officer
Dec 07, 2023	studer jacqueline	acquired	-	-	69,750	chief legal officer
Nov 02, 2023	martucci walter edward ii	sold (taxes)	-2,091	0.3918	-5,337	-
Nov 02, 2023	shanbhag santosh	sold (taxes)	-379	0.3918	-969	chief financial officer
Nov 02, 2023	studer jacqueline	sold (taxes)	-720	0.3918	-1,840	chief legal officer

Which funds bought or sold AKLI recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 15, 2024	MORGAN STANLEY	reduced	-20.00	-319	290	-%
May 15, 2024	Temasek Holdings (Private) Ltd	unchanged	-	-2,273,050	3,333,040	0.02%
May 15, 2024	Royal Bank of Canada	added	5.67	-1,000	-	-%
May 15, 2024	MILLENNIUM MANAGEMENT LLC	new	-	8,620	8,620	-%
May 15, 2024	TWO SIGMA SECURITIES, LLC	sold off	-100	-7,893	-	-%
May 15, 2024	Alyeska Investment Group, L.P.	sold off	-100	-327,575	-	-%
May 15, 2024	Tower Research Capital LLC (TRC)	reduced	-30.53	-4,069	2,871	-%
May 15, 2024	SUVRETTA CAPITAL MANAGEMENT, LLC	unchanged	-	-758,739	1,112,560	0.04%
May 15, 2024	Northeast Financial Consultants Inc	unchanged	-	-11,169	16,379	-%
May 15, 2024	Comprehensive Financial Management LLC	unchanged	-	-209,920	307,967	0.01%

Are Funds Buying or Selling AKLI?

Are funds buying AKLI calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own AKLI

No. of Funds

Unveiling Akili Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	cowen aaron	6.0%	4,699,219	SC 13G/A
Feb 12, 2024	neuberger berman group llc	7.38%	5,776,784	SC 13G
Jan 29, 2024	baillie gifford & co	5.96%	4,665,795	SC 13G/A

Recent SEC filings of Akili Inc

View All Filings

Date Filed	Form Type	Document
May 14, 2024	10-Q	Quarterly Report
May 14, 2024	8-K	Current Report
May 06, 2024	4	Insider Trading
May 06, 2024	4	Insider Trading
Apr 30, 2024	8-K	Current Report
Apr 23, 2024	8-K	Current Report
Mar 12, 2024	4	Insider Trading
Mar 12, 2024	4	Insider Trading
Mar 12, 2024	4	Insider Trading
Mar 06, 2024	DEF 14A	DEF 14A

Peers (Alternatives to Akili Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	482.9B	379.5B	9.53%	9.48%	31.44	1.27	12.96%	-25.81%
CI	96.2B	206.0B	-2.11%	32.08%	24.97	0.47	12.55%	-43.95%
HCA	84.6B	66.7B	3.80%	15.55%	15.46	1.27	9.59%	-4.59%
CVS	72.4B	360.9B	-15.92%	-16.78%	9.89	0.2	9.07%	78.49%
CNC	41.7B	155.5B	8.44%	18.66%	15.24	0.27	6.34%	84.42%
DVA	12.3B	12.3B	9.53%	38.52%	15.03	0.99	5.77%	58.74%
UHS	11.9B	14.7B	11.04%	30.82%	14.63	0.81	7.99%	19.23%
MID-CAP
CHE	8.5B	2.3B	-6.47%	5.37%	30.15	3.73	5.96%	18.29%
ACHC	6.2B	3.0B	-5.49%	-7.73%	-545.12	2.06	10.92%	-104.06%
AMEH	2.3B	1.5B	9.06%	20.53%	36.62	1.57	19.34%	40.15%
AMN	2.2B	3.5B	4.01%	-38.44%	15.49	0.64	-27.67%	-62.43%
SMALL-CAP
ADUS	1.8B	1.1B	14.53%	25.72%	27.59	1.67	11.45%	30.74%
BKD	1.3B	3.0B	6.97%	85.25%	-7.66	0.44	4.98%	4.88%
BEAT	54.5M	-	-4.17%	-6.33%	-3.61	-	-	-1.05%
AMS	22.0M	21.6M	16.05%	23.93%	39.79	1.02	9.04%	-50.63%

Akili Inc News

Latest updates

Akili Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2020Q4
Revenue	54.1%	383,000	248,500	114,000	104,400	94,800	85,200	75,600	66,000	79,000	92,000	105,000	-
Cost Of Revenue	-31.3%	173,000	252,000	150,000	137,000	125,000	123,000	97,000	96,000	112,000	83,000	98,000	-
Gross Profit	-57.7%	210,000	497,000	-36,000	-24,000	-14,000	-41,000	-33,000	-30,000	49,000	72,000	7,000	-
Operating Expenses	-8.6%	11,075,000	12,120,000	15,281,000	19,095,000	22,093,000	24,465,000	22,306,000	21,695,000	2,178,252	18,048,000	14,565,000	-
S&GA Expenses	-11.9%	6,892,000	7,824,000	10,648,000	13,011,000	14,451,000	16,911,000	14,948,000	15,391,000	13,993,000	13,292,000	10,526,000	-
R&D Expenses	-2.6%	4,183,000	4,296,000	4,633,000	6,084,000	7,642,000	7,554,000	7,358,000	6,304,000	5,495,000	4,756,000	4,039,000	-
EBITDA Margin	19.0%	-27.42	-33.84	5.42	-5.84	-19.05	-24.98	-188	-151	-112	-14.96	-8.92	-6.35
Interest Expenses	-12.7%	453,000	519,000	635,000	622,000	618,000	496,000	194,000	176,000	173,000	172,000	39,000	-
Income Taxes	-100.0%	-	37,000	-	-	19,000	-	-	-	-	-	-	-
Earnings Before Taxes	12.0%	-9,763,000	-11,094,000	-11,759,000	-20,711,000	-16,796,000	53,236,000	-22,493,000	-21,892,000	-19,611,000	-18,137,000	-14,774,000	-
EBT Margin	18.4%	-28.90	-35.42	3.24	-8.73	-24.60	-28.56	-190	-153	-114	-15.34	-9.14	-6.51
Net Income	12.4%	-9,763,000	-11,147,000	-11,759,000	-20,711,000	-16,815,000	53,236,000	-22,493,000	-21,892,000	-19,610,000	-18,137,000	-14,774,000	-
Net Income Margin	18.4%	-28.93	-35.45	3.22	-8.76	-24.66	-28.56	-190	-153	-114	-15.34	-9.14	-6.51
Free Cashflow	-9.4%	-9,999,000	-9,143,000	-11,594,000	-19,101,000	-20,959,000	-21,212,000	-19,157,000	-22,235,000	-9,067,976	-7,924,416	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet														(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4
Assets	-16.2%	67.00	80.00	93.00	111	125	145	165	55.00	251	81.00	251	174	97.00	20.00
Current Assets	-16.7%	65.00	78.00	91.00	109	121	141	161	51.00	1.00	80.00	1.00	0.00	-	19.00
Cash Equivalents	-16.0%	63.00	75.00	74.00	56.00	88.00	54.00	90.00	41.00	0.00	77.00	1.00	110	-	19.00
Net PPE	22.8%	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	-	1.00	-	-	-	1.00
Liabilities	-21.5%	17.00	22.00	24.00	29.00	32.00	34.00	41.00	30.00	13.00	15.00	8.00	-	-	8.00
Current Liabilities	-13.5%	11.00	13.00	13.00	13.00	11.00	14.00	13.00	11.00	6.00	8.00	0.00	1.00	0.00	4.00
Shareholder's Equity	-14.2%	50.00	59.00	69.00	83.00	92.00	111	124	-	-	-	-	0.00	0.00	-
Retained Earnings	-3.3%	-309	-299	-288	-272	-261	-240	-223	-275	-12.68	-226	-6.33	-6.07	-0.01	-114
Additional Paid-In Capital	0.4%	360	358	358	356	353	351	347	-	-	-	-	-	0.00	10.00
Shares Outstanding	0.4%	79.00	78.00	78.00	78.00	78.00	78.00	14.00	-	2.00	2.00	1.00	1.00	6.00	1.00
Float	-	-	-	-	67.00	-	-	-	247	-	-	-	251	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)															(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2021Q1	2020Q4
Cashflow From Operations	-9.4%	-9,996	-9,137	-18,045	-11,587	-19,098	-20,959	-21,183	-19,154	-22,225	-9,055	-7,917	-19.84	-	-	-
Share Based Compensation	134.2%	1,302	556	1,655	1,837	2,759	2,117	3,153	1,969	2,070	1,365	1,748	-	-	-	-
Cashflow From Investing	-101.9%	-230	12,370	37,497	-19,369	52,915	-14,581	-61,648	9,997	-14,984	-6.00	-377	-	-	-	-
Cashflow From Financing	-0.3%	-1,888	-1,882	-1,919	-647	-45.00	-24.00	131,854	10,041	64.00	45.00	125,786	243	-	-	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

AKLI Income Statement

2024-03-31

Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Revenues	$ 383	$ 113
Cost of revenues	173	137
Gross profit (loss)	210	(24)
Operating expenses:
Research and development	4,183	6,084
Selling, general and administrative	6,892	13,011
Total operating expenses	11,075	19,095
Operating loss	(10,865)	(19,119)
Other income (expense):
Other income	667	1,043
Interest expense	(453)	(622)
Change in estimated fair value of earn-out liabilities	888	(2,013)
Total other income (expense)	1,102	(1,592)
Loss before income taxes	(9,763)	(20,711)
Net loss	(9,763)	(20,711)
Unrealized gain on short-term investments		23
Comprehensive loss	(9,763)	(20,688)
Net loss	$ (9,763)	$ (20,711)
Weighted average common stock outstanding - basic	78,526,669	78,079,013
Weighted average common shares outstanding - diluted	78,526,669	78,079,013
Net loss per share - basic	$ (0.12)	$ (0.27)
Net loss per share - diluted	$ (0.12)	$ (0.27)

AKLI Balance Sheet

2024-03-31

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 63,161	$ 75,150
Restricted cash	180	305
Accounts receivable	144	300
Prepaid expenses and other current assets	1,513	2,275
Total current assets	64,998	78,030
Property and equipment, net	835	680
Operating lease right-of-use asset	1,442	1,577
Prepaid expenses and other long-term assets	90	96
Total assets	67,365	80,383
Current liabilities:
Accounts payable	1,101	1,285
Accrued expenses and other current liabilities	1,794	3,326
Deferred revenue	38	100
Operating lease liability	779	756
Note payable, short term	7,500	7,500
Total current liabilities	11,212	12,967
Note payable, long term	1,671	3,445
Operating lease liability, net of current portion	1,528	1,730
Corporate bond, net of bond discount	2,115	2,054
Earn-out liabilities	608	1,632
Other long-term liabilities	23	23
Total liabilities	17,157	21,851
Commitments and contingencies
Stockholders' equity
Common stock, $0.0001 par value: 1,000,000,000 shares authorized; 78,684,864 and 78,356,527 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively	8	8
Additional paid-in capital	359,744	358,305
Accumulated deficit	(309,544)	(299,781)
Total stockholders' equity	50,208	58,532
Total liabilities and stockholders' equity	$ 67,365	$ 80,383

About Akili Inc

Akili, Inc., a digital medicine company, develops cognitive treatments through game-changing technologies. The company provides EndeavorRx, a computer-based testing for cognitive dysfunction across several neurology and psychiatry indications, including attention-deficit hyperactivity disorder, depressive disorder, autism spectrum disorder, multiple sclerosis, and other neuroinflammatory diseases. It offers selective stimulus management engine mechanism to activate the fronto-parietal cortex area in the brain; body brain trainer for attention, impulsivity, working memory, and goal management; and spatial navigation engine for spatial navigation, memory, and planning and organization. Akili, Inc. was founded in 2011 and is headquartered in Boston, Massachusetts.

CEO	Dr. Walter Edward Martucci II, Ph.D.
WEBSITE	akiliinteractive.com
INDUSTRY	Healthcare Plans
EMPLOYEES	111

Akili Inc Frequently Asked Questions

What is the ticker symbol for Akili Inc? What does AKLI stand for in stocks?

AKLI is the stock ticker symbol of Akili Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Akili Inc (AKLI)?

As of Fri May 17 2024, market cap of Akili Inc is 33.83 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AKLI stock?

You can check AKLI's fair value in chart for subscribers.

What is the fair value of AKLI stock?

You can check AKLI's fair value in chart for subscribers. The fair value of Akili Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Akili Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for AKLI so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Akili Inc a good stock to buy?

The fair value guage provides a quick view whether AKLI is over valued or under valued. Whether Akili Inc is cheap or expensive depends on the assumptions which impact Akili Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AKLI.

What is Akili Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, AKLI's PE ratio (Price to Earnings) is -0.7 and Price to Sales (PS) ratio is 20.16. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AKLI PE ratio will change depending on the future growth rate expectations of investors.